VYNE Therapeutics Inc. Gains 45.83%
VYNE Therapeutics Inc. (VYNE:NASDAQ) shot up at $0.28, a gain of 45.8%. On Tue, Jan 10, 2023, VYNE:NASDAQ touched a New 2-Week High of $0.28. The stock appeared on our News Catalysts scanner on Mon, Jan 09, 2023 at 04:53 PM in the 'BIOTECH' category. From Tue, Dec 27, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Tue, Jan 10, 2023 at $0.38 with a volume of 33M+.
About VYNE Therapeutics Inc. (VYNE:NASDAQ)
VYNE Therapeutics Inc is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology.
Top 10 Gainers:
- Biora Therapeutics Inc. (BIOR:NASDAQ), 155.92%
- Party City Holdco Inc. (PRTY:NYSE), 117.91%
- Sotera Health Company (SHC:NASDAQ), 99.65%
- DatChat Inc. (DATS:NASDAQ), 56.46%
- DermTech, Inc. (DMTK:NASDAQ), 47.25%
- Boxed Inc. (BOXD:NYSE), 46.2%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 45.83%
- Elys Game Technology Corp. (ELYS:NASDAQ), 41.9%
- Ebang International Holdings Inc. (EBON:NASDAQ), 41.48%
- Jianzhi Education Technology Group Company Limited (JZ:NASDAQ), 40.83%